Uso de la hidroxiurea para la enfermedad de células falciformes

Uso de la hidroxiurea para la enfermedad de células falciformes.

Other author/creator	National Heart, Lung, and Blood Institute, issuing body.
Format	Electronic and Book
Publication Info	[Bethesda, Md.] : U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, 2024.
Description	1 online resource (2 unnumbered pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo223754
Subject(s)	Sickle cell anemia--Treatment. Antineoplastic agents--Therapeutic use. Urea--Derivatives --Therapeutic use.

Uniform title	Hydroxyurea use for sickle cell disease. Spanish.
Series	NIH Publication ; no. 24-HL-8219S NIH publication ; no. 24-HL-8219S.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	"February 2024."
General note	"Blood diseases & disorders education program."
General note	GPO Cataloging Record Distribution Program (CRDP).
Language	Texr in Spanish.
Source of description	Description based on online resource; title from PDF caption (NHLBI, viewed March 30, 2024).
Other edition issued	Issued also as: Hydroxyurea use for sickle cell disease
GPO item number	0507-E-01 (online)
Govt. docs number	HE 20.3202:H 99/18/SPAN.

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	Access Content Online	✔ Available